Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  BioNTech SE    BNTX

BIONTECH SE

(BNTX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/31/2020 08/03/2020 08/04/2020 08/05/2020 08/06/2020 Date
82.11(c) 85.47(c) 83.17(c) 81.3(c) 77.71 Last
2 642 973 2 434 416 2 410 338 4 085 523 1 834 661 Volume
-2.44% +4.09% -2.69% -2.25% -4.42% Change
More quotes
Financials
Sales 2020 131 M 155 M 155 M
Net income 2020 -82,5 M -97,5 M -97,5 M
Net cash position 2020 962 M 1 138 M 1 138 M
P/E ratio 2020 -109x
Yield 2020 -
Sales 2021 1 173 M 1 387 M 1 387 M
Net income 2021 232 M 274 M 274 M
Net cash position 2021 2 164 M 2 558 M 2 558 M
P/E ratio 2021 224x
Yield 2021 -
Capitalization 16 309 M 19 364 M 19 276 M
EV / Sales 2020 117x
EV / Sales 2021 12,1x
Nbr of Employees 1 400
Free-Float 95,0%
More Financials
Company
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer... 
More about the company
Surperformance© ratings of BioNTech SE
Trading Rating : Investor Rating :
More Ratings
Latest news on BIONTECH SE
09:15aBIONTECH SE : half-yearly earnings release
07:43aAstraZeneca in first COVID-19 vaccine deal with Chinese company
RE
06:01aBioNTech to Report Second Quarter 2020 Financial Results and Operational Upda..
GL
05:34aAstraZeneca in first COVID-19 vaccine deal with Chinese company
RE
08/05U.S. to pay $1 billion for 100 million doses of J&J's COVID-19 vaccine candid..
RE
08/05Covid-19 Vaccine Makers Signal Prices
DJ
08/05Canada signs deals with Pfizer, Moderna for experimental COVID-19 vaccines
RE
08/05Moderna prices COVID-19 vaccine at $32-$37 per dose for smaller volume deals
RE
08/05Canada signs deals with Pfizer, Moderna for experimental COVID-19 vaccines
RE
08/05Pfizer, BioNTech in Deal to Supply Canada With Covid-19 Vaccine Candidate
DJ
08/05Pfizer and BioNTech to Supply Canada with their BNT162 mRNA-Based Vaccine Can..
GL
08/05BIONTECH : Shanghai Fosun Pharma Dose Participants in China Covid-19 Vaccine Tri..
DJ
08/05COVID-19 VACCINE TRIALS HAVE A PROBL : Minority Groups Don't Trust Them
DJ
08/05Valneva sees full UK investment in possible COVID vaccine sealed within weeks
RE
08/05BioNTech and Fosun Pharma Announce Start of Clinical Trial of mRNA-based COVI..
GL
More news
News in other languages on BIONTECH SE
09:15aBIONTECH SE : half-yearly earnings release
08:19aJeff Bezos vend des actions Amazon pour un montant de 3 mds de dollars
07:43aAstraZeneca in first COVID-19 vaccine deal with Chinese company
06:01aBioNTech to Report Second Quarter 2020 Financial Results and Operational Upda..
05:34aAstraZeneca in first COVID-19 vaccine deal with Chinese company
More news
Chart BIONTECH SE
Duration : Period :
BioNTech SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIONTECH SE
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Average target price 61,58 €
Last Close Price 68,48 €
Spread / Highest target 23,8%
Spread / Average Target -10,1%
Spread / Lowest Target -45,5%
EPS Revisions
Managers
NameTitle
Ugur Sahin Chief Executive Officer
Helmut Jeggle Chairman-Supervisory Board
Sierk Pötting Chief Operating & Financial Officer
Özlem Türeci Chief Medical Officer
Christoph Huber Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
BIONTECH SE139.96%19 364
GILEAD SCIENCES, INC.6.19%86 552
VERTEX PHARMACEUTICALS24.79%71 167
REGENERON PHARMACEUTICALS66.33%65 719
WUXI APPTEC CO., LTD.73.86%39 839
GENMAB A/S52.68%23 610